World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
31126
World Ranking
15451
National Ranking
1421

Overview

Nick Thatcher is affiliated with the University of Manchester in the United Kingdom. Their academic and professional activities are connected to this institution.

The available data does not include specific details about their recent publications, co-authors, frequent publication venues, or their contributions to book publications. Additionally, no information regarding their main fields of study, subfields, or specific research topics is recorded.

There are no recorded awards associated with Nick Thatcher. The data does not indicate any honors or recognitions granted over the course of their career.

As no information about publications is provided, summative lists of papers, including titles, years, and venues, cannot be offered.

Best Publications

  • Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

    Nick Thatcher;Alex Chang;Purvish Parikh;José Rodrigues Pereira

  • Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

    Mark R Middleton;J J Grob;N Aaronson;G Fierlbeck

  • Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer

    Fred R. Hirsch;Marileila Varella-Garcia;Paul A. Bunn;Wilbur A. Franklin

  • Therapeutic vaccines for cancer: an overview of clinical trials

    Ignacio Melero;Gustav Gaudernack;Winald Gerritsen;Christoph Huber

  • Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.

    M. H. Bronchud;J. H. Scarffe;N. Thatcher;D. Crowther

  • Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials

    Sarah Burdett;S. Burdett;R. Stephens;L. Stewart

  • Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer

    Mary E.R. O'Brien;Tudor-Eliade Ciuleanu;Hristo Tsekov;Yaroslav Shparyk

  • Alternate splicing produces a novel cyclin D1 transcript.

    D. C. Betticher;N. Thatcher;H. J. Altermatt;P. Hoban

  • Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

    Charles Butts;Mark A Socinski;Paul L R Mitchell;Nick Thatcher

  • Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.

    Heather Anderson;B Lund;F Bach;Nick Thatcher

  • Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer.

    Heather Anderson;Penelope Hopwood;R J Stephens;Nick Thatcher

  • Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study

    Sanjiv S. Agarwala;John M. Kirkwood;Martin Gore;Brigitte Dreno

  • Randomized Trial of Paclitaxel Plus Supportive Care Versus Supportive Care for Patients With Advanced Non-Small-Cell Lung Cancer

    Malcolm R Ranson;Neville Davidson;Marianne Nicolson;Stephen J Falk

  • Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.

    T Le Chevalier;G Scagliotti;R Natale;S Danson

  • Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.

    Nick Thatcher;Fred R Hirsch;Alexander V Luft;Aleksandra Szczesna

  • Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.

    N M Bleehen;E S Newlands;Siow Ming Lee;Nick Thatcher

  • Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study

    Lucio Crinò;Eric Dansin;Pilar Garrido;Frank Griesinger

  • Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

    D. C. Betticher;J. Heighway;P. S. Hasleton;H. J. Altermatt

  • Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

    Barry W Hancock;Keith Wheatley;S Harris;Natalie J Ives

  • Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study.

    Alex Chang;Purvish Parikh;Sumitra Thongprasert;Eng Huat Tan

Frequent Co-Authors

Paul Lorigan
Paul Lorigan University of Manchester
Fiona H Blackhall
Fiona H Blackhall University of Manchester
Mark A. Socinski
Mark A. Socinski University of North Carolina at Chapel Hill
Luis Paz-Ares
Luis Paz-Ares Complutense University of Madrid
Geoffrey P. Margison
Geoffrey P. Margison University of Manchester
John Radford
John Radford University of Manchester
Frances A. Shepherd
Frances A. Shepherd Princess Margaret Cancer Centre
Martin Reck
Martin Reck LungenClinic Grosshansdorf
Mark R. Middleton
Mark R. Middleton University of Oxford
Corey J. Langer
Corey J. Langer University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers but seeking alternative routes to a traditional MD program, there are several online degrees and certifications worth considering. Online ADN programs allow students to pursue an Associate Degree in Nursing from the comfort of home, making it easier for working professionals or those with family commitments to enter nursing.

Administrative healthcare roles are also growing in demand. If managing hospital operations or patient records appeals to you, a healthcare administration online degree can offer flexible coursework and a quick pathway into the field.

Medical billing and coding is another rewarding career with plentiful opportunities. Many online medical billing and coding schools that accept fafsa exist for those needing financial assistance.

For aspiring practical nurses, some schools do not require the traditional pre-admission tests. If you're wondering, do you have to take a teas test for lpn, it's worth exploring schools with less stringent entrance exams to accelerate your entry into the field.

Best Scientists Citing Nick Thatcher

Trending Scientists